Linnaeus Therapeutics announced it raised $1.63 Million in an initial filing from an offering of $3.92 Million
Aug 12, 2024•over 1 year ago
Amount Raised
$1.63 Million
HaddonfieldresearchBiotechnology
Company Information
Company
Linnaeus Therapeutics
Location
30 WASHINGTON AVENUE, SUITE F
Haddonfield, New Jersey, United States
About
Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).